Metraipolis › archive › dc_367a8dff0834

Case report of non-gene editing CD7 CAR T cell therapy in CD7⁺ Sézary syndrome: preclinical validation and first-in-human use — Europe PMC PMID:40821791

Source

Europe PMC (en)

Original

https://europepmc.org/article/MED/40821791

DOI

10.3389/fimmu.2025.1604490

License (as archived)

solo-consultazione

Archived

2026-10-06T08:13:00.811Z

SHA-256 of the archived text

5238fc5eb832010c9ba3c40ce03e18d33570f97de43f19b018501446abd6a4ac

Stable URL of this page

https://metraipolis.com/documento/dc_367a8dff0834

How to cite

Case report of non-gene editing CD7 CAR T cell therapy in CD7<sup>+</sup> Sézary syndrome: preclinical validation and first-in-human use — Europe PMC PMID:40821791 — Europe PMC (en), https://europepmc.org/article/MED/40821791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_367a8dff0834 (Metraipolis archive dc_367a8dff0834, sha256 5238fc5eb832010c9ba3c40ce03e18d33570f97de43f19b018501446abd6a4ac)

@misc{dc367a8dff0834,
  title = {Case report of non-gene editing CD7 CAR T cell therapy in CD7<sup>+</sup> Sézary syndrome: preclinical validation and first-in-human use — Europe PMC PMID:40821791},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40821791},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_367a8dff0834; sha256 5238fc5eb832010c9ba3c40ce03e18d33570f97de43f19b018501446abd6a4ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40821791. Agents can read the archived copy with the MCP tool read_document.